Helena Chang, MD, delves into the medical management of kidney stones, highlighting current guidelines, challenges, and future directions. In this 15-minute presentation, Dr. Chang emphasizes the prevalence of kidney stones, affecting over 10% of Americans, and the critical need for effective metabolic workups to reduce recurrence.
She explains the current AUA guidelines, covering evaluation, dietary interventions, pharmacologic therapies, and follow-up. She acknowledges the widespread use of pharmacologic interventions like thiazide diuretics and potassium citrate but identifies gaps in adherence and follow-up testing.
Dr. Chang envisions a future shaped by randomized trials, artificial intelligence, and multidisciplinary approaches, including advanced practice providers and pharmacist-led telemedicine programs. She stresses the importance of incorporating stone recurrence as a measurable endpoint in future studies, moving beyond surrogate markers from urine studies.
She explains the current AUA guidelines, covering evaluation, dietary interventions, pharmacologic therapies, and follow-up. She acknowledges the widespread use of pharmacologic interventions like thiazide diuretics and potassium citrate but identifies gaps in adherence and follow-up testing.
Dr. Chang envisions a future shaped by randomized trials, artificial intelligence, and multidisciplinary approaches, including advanced practice providers and pharmacist-led telemedicine programs. She stresses the importance of incorporating stone recurrence as a measurable endpoint in future studies, moving beyond surrogate markers from urine studies.
- Category
- Urology

Be the first to comment